Cargando…
Effect of pravastatin on erythrocyte membrane fatty acid contents in patients with chronic kidney disease
BACKGROUND: Statin treatment has decreased the risk of cardiovascular events in patients with chronic kidney disease (CKD). Erythrocyte membrane oleic acid level is higher in patients with acute coronary syndrome. This study aimed to evaluate the effect of pravastatin on the erythrocyte membrane fat...
Autores principales: | Lee, Su Mi, Son, Young Ki, Kim, Seong Eun, Kim, Yeong Hoon, Park, Yongsoon, An, Won Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Nephrology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476301/ https://www.ncbi.nlm.nih.gov/pubmed/34078022 http://dx.doi.org/10.23876/j.krcp.20.247 |
Ejemplares similares
-
Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy
por: Lee, Su Mi, et al.
Publicado: (2015) -
Omega-3 fatty acid decreases oleic acid by decreasing SCD-1 expression in the liver and kidney of a cyclosporine-induced nephropathy rat model
por: Lee, Su Mi, et al.
Publicado: (2019) -
Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease
por: Kim, Oh Yoen, et al.
Publicado: (2018) -
Effect of Omega-3 Fatty Acid on STAMP2 Expression in the Heart and Kidney of 5/6 Nephrectomy Rat Model
por: Lee, Hye Won, et al.
Publicado: (2018) -
Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study
por: Harisa, Gamal El-din I., et al.
Publicado: (2011)